Nashville Oncology Associates

Pregnancy outcomes following exposure to galcanezumab: Analysis of cases from the galcanezumab clinical trials and postmarketing database

OBJECTIVE: This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. BACKGROUND: Galcanezumab is a calcitonin gene-related peptide-inhibiting monoclonal antibody indi...